Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Chronic Heart Failure

  Free Subscription


20.07.2026

1 Am Heart J
1 Basic Res Cardiol
1 BMJ
1 Cardiovasc Res
2 Circ Heart Fail
1 Circ Res
11 Eur J Heart Fail
1 Heart
1 Int J Cardiol
1 J Am Coll Cardiol
9 J Card Fail
1 J Cardiovasc Pharmacol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. MARWICK TH
    Empagliflozin and Functional Capacity in Patients at Risk of Heart Failure.
    Am Heart J. 2026 Jul 17:107541. doi: 10.1016/j.ahj.2026.107541.
    PubMed        


    Basic Res Cardiol

  2. MIRA HERNANDEZ J, Bailey LRJ, Salemme VR, Ko CY, et al
    Empagliflozin restores cardiac function in obese-diabetic HFpEF mice but further alters gene expression.
    Basic Res Cardiol. 2026;121:669-688.
    PubMed         Abstract available


    BMJ

  3. WILKINSON E
    New heart failure treatment approved by NICE.
    BMJ. 2026;394:e100305.
    PubMed        


    Cardiovasc Res

  4. NIKOLAEV VO, Gorelik J
    Cardiomyocyte T-tubule loss in heart failure - NFkappaB as a central signalling hub.
    Cardiovasc Res. 2026 Jul 14:cvag148. doi: 10.1093.
    PubMed        


    Circ Heart Fail

  5. ALI Z, Anwar M, Subhani W
    Letter by Ali et al Regarding Article "Resolution of Systemic Inflammation in Patients With Recently Decompensated Heart Failure With Reduced Ejection Fraction With and Without Interleukin-1 Blockade by Anakinra".
    Circ Heart Fail. 2026 Jul 15:e014565. doi: 10.1161/CIRCHEARTFAILURE.126.014565.
    PubMed        

  6. WEERAHANDI H, Behar E, Ceralde C, Nguyen ND, et al
    Skilled Nursing Facility-to-Home Transitions After Heart Failure Hospitalization: A Mixed-Methods Study of Communication, Self-Care, Medication, and Follow-Up.
    Circ Heart Fail. 2026 Jul 14:e014449. doi: 10.1161/CIRCHEARTFAILURE.126.014449.
    PubMed         Abstract available


    Circ Res

  7. PATEL TA, Rose J, Katsurada K, Yada T, et al
    GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight.
    Circ Res. 2026;139:e327683.
    PubMed         Abstract available


    Eur J Heart Fail

  8. ANKER MS, Lang NN, Pellicori P
    Too Hot To Sleep? Circadian Temperature Control in Heart Failure.
    Eur J Heart Fail. 2026 Jul 18:xuag227. doi: 10.1093.
    PubMed        

  9. LABORANTE R, Bianchini E, Beer BN, Valente V, et al
    A NETwork meta-analysis with COST-effectiveness evaluation of pharmacological treatments for Heart Failure with Reduced Ejection Fraction: NET-COST-HFrEF.
    Eur J Heart Fail. 2026 Jul 16:xuag233. doi: 10.1093.
    PubMed         Abstract available

  10. IACONELLI A, Busti M, Sensini L, Dolce P, et al
    Catheter ablation of atrial fibrillation in patients with heart failure: a trial-level meta-analysis.
    Eur J Heart Fail. 2026 Jul 16:xuag232. doi: 10.1093.
    PubMed         Abstract available

  11. BIEGUS J, Iwanek G, Testani J, Zymlinski R, et al
    Urinary Biomarker Thresholds to Detect Diuretic Resistance and Insufficient Diuretic Response in Acute Heart Failure.
    Eur J Heart Fail. 2026 Jul 16:xuag216. doi: 10.1093.
    PubMed         Abstract available

  12. ZHOU X, Liu H, Hua Z
    Early SGLT2 Inhibition in Acute Heart Failure: When More Urine Does Not Necessarily Mean Better Decongestion.
    Eur J Heart Fail. 2026 Jul 15:xuag221. doi: 10.1093.
    PubMed        

  13. WEYRICH M, Ware A, Windschmitt J, Sarakpi T, et al
    Response to the letter by Tang and Liu Regarding our article "Independent and Dose-Dependent Contributions of Clonal Hematopoiesis and Mosaic Loss of Y to Incident Heart Failure".
    Eur J Heart Fail. 2026 Jul 15:xuag219. doi: 10.1093.
    PubMed        

  14. KRESOJA KP, Stolz L, Cannata A, Rommel KP, et al
    Rethinking Tricuspid Valve Regurgitation in Heart Failure - A Pathophysiology-based Holistic Approach for Individualized Patient Management.
    Eur J Heart Fail. 2026 Jul 15:xuag226. doi: 10.1093.
    PubMed         Abstract available

  15. KATZMANN JL, Abdelhamid M, Laufs U
    Cholesterol-lowering and heart failure.
    Eur J Heart Fail. 2026 Jul 14:xuag185. doi: 10.1093.
    PubMed        

  16. DOCHERTY KF, Petrie MC, McKinley G, Bear G, et al
    Cardiac myosin-binding protein C in community-based patients with suspected heart failure.
    Eur J Heart Fail. 2026 Jul 14:xuag143. doi: 10.1093.
    PubMed         Abstract available

  17. RAZAGHIZAD A, Vasques-Novoa F, Ni J, Ferreira JP, et al
    PCSK9 inhibition and cardiovascular outcomes by heart failure status: a pooled analysis of SPIRE-1 and SPIRE-2.
    Eur J Heart Fail. 2026 Jul 14:xuag166. doi: 10.1093.
    PubMed        

  18. ELSANHOURY A, Eschenhagen T, Van Linthout S
    Cardiac myosin-binding protein C, an incremental heart failure biomarker?
    Eur J Heart Fail. 2026 Jul 14:xuag148. doi: 10.1093.
    PubMed        


    Heart

  19. MU L, Larvin H, Nadarajah R, Gale CP, et al
    Long-term cardiovascular risks after atrial fibrillation diagnosis: a systematic review and meta-analysis.
    Heart. 2025 Sep 17:heartjnl-2025-326376. doi: 10.1136/heartjnl-2025-326376.
    PubMed         Abstract available


    Int J Cardiol

  20. AGOSTONI P, Salvioni E, Pezzuto B, Chiesa M, et al
    Heart failure evolution, the chimera of our wishes.
    Int J Cardiol. 2026 Jul 14:134669. doi: 10.1016/j.ijcard.2026.134669.
    PubMed        


    J Am Coll Cardiol

  21. QIU N, Liu X, Wang Z, Wang W, et al
    Randomized Trial of Left Bundle Branch Pacing vs Right Ventricular Pacing in Vulnerable Cardiac Function.
    J Am Coll Cardiol. 2026;88:188-201.
    PubMed         Abstract available


    J Card Fail

  22. VICTORES A, Bash LD, Ru B, Marks-Anglin A, et al
    Characterizing real-world use of vericiguat in the United States.
    J Card Fail. 2026;32:1153-1161.
    PubMed         Abstract available

  23. URIEL N, Netuka I, Jorde UP, Pagani FD, et al
    Impact of Atrial Fibrillation, Diabetes Mellitus, and Obesity on Outcomes With Aspirin Avoidance and Hemocompatibility With a Left Ventricular Assist Device: An Analysis From the ARIES-HM3 Trial.
    J Card Fail. 2026;32:1224-1233.
    PubMed         Abstract available

  24. GYBERG DJ, Komtebedde J, Mylavarapu U, Litwin SE, et al
    Refining Atrial Shunt Therapy for Heart Failure With Preserved Ejection Fraction: Lessons From Pivotal Randomized Trials and Emerging Directions.
    J Card Fail. 2026;32:1246-1256.
    PubMed         Abstract available

  25. YI H, Drager LF, Wang X, Kasai T, et al
    SLEEP-DISORDERED BREATHING IN HEART FAILURE: PHENOTYPES, MECHANISMS, AND PRECISION APPROACH.
    J Card Fail. 2026 Jul 10:S1071-9164(26)00387.
    PubMed         Abstract available

  26. SELVADURAI MV, Dagan M, Mariani J, Vizi D, et al
    An abbreviated exercise right heart catheterization protocol for the diagnosis of heart failure with preserved ejection fraction.
    J Card Fail. 2026 Jul 11:S1071-9164(26)00402.
    PubMed         Abstract available

  27. OGAH OS, Orimolade OA, Anyikwa CL, Onuigbo A, et al
    Generating Much-Needed Heart Failure-Related Outcome Data in Sub-Saharan Africa: Insights from the Ibadan Heart Failure Project.
    J Card Fail. 2026 Jul 14:S1071-9164(26)00219.
    PubMed        

  28. DISTEFANO J, Pierson NW
    Unintended Financial Barriers: When "Generic" Does Not Mean Affordable.
    J Card Fail. 2026;32:1285-1287.
    PubMed         Abstract available

  29. LAU ES, Shnitzer T, Roshandelpoor A, Friedman S, et al
    Deep learning interpretation of echocardiographic images predicts incident heart failure and subtypes.
    J Card Fail. 2026 Jul 15:S1071-9164(26)00400.
    PubMed         Abstract available

  30. GUILLIOD CR, Blumer V, De Oliveira-Gomes D, Abraham WT, et al
    Demographic Enrollment by Region in Heart Failure Trials: Insights from GUIDE-IT and HF-ACTION.
    J Card Fail. 2026 Jul 16:S1071-9164(26)00401.
    PubMed        


    J Cardiovasc Pharmacol

  31. KELLY J, Mezzaroma E, Roscioni A, McSkimming C, et al
    INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED WITH ANAKINRA.
    J Cardiovasc Pharmacol. 2026 Jul 1. doi: 10.1097/FJC.0000000000001849.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum